Celent Report : Optimizing the OTC Pricing and Valuation Infrastructure
Total Cost of Analytics - It's More than You Think
Most organizations are largely unaware of the total costs associated with building their own derivatives analytics library. It is safe to say that if companies were aware of the full realm of costs, most would re-think their development and deployment efforts in the pursuit of greater efficiency and Return on Investment.
This analyst report is available for qualified financial professionals at no charge.
Request your complimentary copy of this eye-opening study by Celent to discover key areas that continue to plague firms involved with in-house derivatives analytics systems. See how significant duplication of analytics across front, middle and back offices are further compounded by indirect costs, inefficiencies and integration expenses.
"Firms adopting in-house strategies for OTC pricing will require investments between $25 to $36 million alone to build out, maintain and enhance a complete derivatives library," Celent.
Request your copy of the Celent Report to:
- Identify cost-accumulating areas that may be hampering your organization
- Discover key steps your organization can take to improve ROI
- Re-examine how internal development efforts bring differentiation